|
Post by JHam on Oct 2, 2018 1:37:51 GMT
10% drop......bought a small position again....I can't see a continued downturn...gotta be alot of bagholders at $14.50 no? Yeah I don't see it either. It could be selling of warrants from a deal from a few years ago, but it is probably just a shaking of the trees. I think we'll probably see a lot of this kind of action for the foreseeable future, to be honest. It doesn't take much to move this one cause of the low float. As institutions continue to come in and buy in big chunks, there will be traders riding their coattails.
|
|
|
Post by JHam on Oct 2, 2018 5:07:48 GMT
|
|
|
Post by magnus123 on Oct 2, 2018 12:27:36 GMT
If Catasys falls down under $11, i will also buy additional shares. Yesterday wasnt nice, but its normal for a company with such an extremely tiny float.
Q3 earnings will be very important, i believe. I hope for a guidance raise for FY2018 and first outlook into 2019.
|
|
|
Post by magnus123 on Oct 4, 2018 15:25:27 GMT
I bought now an additional decent amount of shares. Hope for a recovery through $12-13.
|
|
|
Post by JHam on Oct 19, 2018 0:47:16 GMT
It's been a couple rough weeks for CATS. Nothing fundamentally has changed so I continue to hold on tight. If it dips below my cost average or back into the $7s I will probably add. It's been suggested by Tailwinds Research (who covers CATS) that the selloff is likely due to a warrant holder from a few years back dumping. Looking forward to the Q3 report.
|
|
|
Post by JHam on Oct 23, 2018 14:51:18 GMT
Aaaand welcome back to the $7s. Brutal...
|
|
|
Post by lcd on Oct 23, 2018 17:26:45 GMT
I have been busy with work and can't check the market often so I never noticed the pps drop below $8.50 today until seeing your post. It is back up around yesterday's close now, but with such a small float this one is extremely susceptible to larger market fluctuations. I am tempted to buy more at this price, but I fear a larger market sell off will continue so I am not buying any stocks right now.
|
|
|
Post by JHam on Oct 24, 2018 2:28:03 GMT
I have been busy with work and can't check the market often so I never noticed the pps drop below $8.50 today until seeing your post. It is back up around yesterday's close now, but with such a small float this one is extremely susceptible to larger market fluctuations. I am tempted to buy more at this price, but I fear a larger market sell off will continue so I am not buying any stocks right now.Nice recovery there at the end of the day. I totally agree with the highlighted above. I really want to buy more of this, but for the reasons you've mentioned, especially as we head towards the election, I'm holding off for now as well.
|
|
|
Post by JHam on Oct 24, 2018 2:41:16 GMT
|
|
|
Post by magnus123 on Oct 31, 2018 12:37:33 GMT
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has entered into an agreement with Capital BlueCross, a community-based health insurer serving members in 21 counties in Central Pennsylvania and the Lehigh Valley. Beginning the first quarter of 2019, eligible Capital BlueCross commercial members will be able to take advantage of Catasys’ OnTrak solution, an integrated 52-week program that identifies, engages and treats members with untreated behavioral health conditions that exacerbate chronic medical disease and result in unnecessarily higher medical costs. “Reaching members who are dealing with behavioral health conditions is critically important to their treatment and recovery. By utilizing Catasys’ OnTrak, we are able to provide help to those who previously would have been difficult to identify,” said Dr. Jennifer Chambers, Chief Medical Officer and Senior Vice President Clinical Solutions. “Depression, anxiety and substance use disorders can lead to other conditions affecting overall health and wellness. In working with Catasys to identify members who are in need of valuable behavioral health services, we look forward to seeing the positive impacts of this partnership.” OnTrak specifically addresses anxiety, depression and substance use disorders among health plan members who may avoid behavioral care, and whose untreated or undertreated behavioral conditions negatively impact co-morbid medical conditions. By uniquely engaging these members in a program that produces durable behavior change, OnTrak can significantly improve the quality of members’ lives while reducing healthcare costs. “We are excited to begin this partnership with Capital BlueCross,” said Rick Anderson, Catasys President and Chief Operating Officer. “We look forward to supporting eligible members of this health plan, who are often suffering in silence, with our integrated OnTrak program that can dramatically improve their lives.” About Catasys, Inc. Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives. Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven engagement technologies. OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, Nebraska, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. About Capital BlueCross Capital BlueCross, headquartered in Harrisburg, Pa., is the leading health solutions and insurance company in Central Pennsylvania and the Lehigh Valley. A partner in the community’s health for 80 years, Capital BlueCross offers health insurance products, services and technology solutions that provide peace of mind to consumers and promote health and wellness for our customers. More than a health insurer, the company delivers innovative solutions through a family of diversified businesses that is creating a healthier future and lowering health care costs. Among these solutions are patient-focused care models, leading-edge data analytics, and digital health technologies. Additionally, Capital BlueCross is growing a network of Capital Blue health and wellness centers that provide in-person service and inspiration to help people reach their health goals. Capital BlueCross is an independent licensee of the BlueCross BlueShield Association. For more information, visit capbluecross.com. Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. View source version on businesswire.com: www.businesswire.com/news/home/20181031005224/en/Catasys, Inc. Patricia Rouhafza, 310-444-4346 Copyright Business Wire 2018
|
|
|
Post by JHam on Oct 31, 2018 12:46:15 GMT
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has entered into an agreement with Capital BlueCross, a community-based health insurer serving members in 21 counties in Central Pennsylvania and the Lehigh Valley. Beginning the first quarter of 2019, eligible Capital BlueCross commercial members will be able to take advantage of Catasys’ OnTrak solution, an integrated 52-week program that identifies, engages and treats members with untreated behavioral health conditions that exacerbate chronic medical disease and result in unnecessarily higher medical costs. “Reaching members who are dealing with behavioral health conditions is critically important to their treatment and recovery. By utilizing Catasys’ OnTrak, we are able to provide help to those who previously would have been difficult to identify,” said Dr. Jennifer Chambers, Chief Medical Officer and Senior Vice President Clinical Solutions. “Depression, anxiety and substance use disorders can lead to other conditions affecting overall health and wellness. In working with Catasys to identify members who are in need of valuable behavioral health services, we look forward to seeing the positive impacts of this partnership.” OnTrak specifically addresses anxiety, depression and substance use disorders among health plan members who may avoid behavioral care, and whose untreated or undertreated behavioral conditions negatively impact co-morbid medical conditions. By uniquely engaging these members in a program that produces durable behavior change, OnTrak can significantly improve the quality of members’ lives while reducing healthcare costs. “We are excited to begin this partnership with Capital BlueCross,” said Rick Anderson, Catasys President and Chief Operating Officer. “We look forward to supporting eligible members of this health plan, who are often suffering in silence, with our integrated OnTrak program that can dramatically improve their lives.” About Catasys, Inc. Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives. Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven engagement technologies. OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, Nebraska, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. About Capital BlueCross Capital BlueCross, headquartered in Harrisburg, Pa., is the leading health solutions and insurance company in Central Pennsylvania and the Lehigh Valley. A partner in the community’s health for 80 years, Capital BlueCross offers health insurance products, services and technology solutions that provide peace of mind to consumers and promote health and wellness for our customers. More than a health insurer, the company delivers innovative solutions through a family of diversified businesses that is creating a healthier future and lowering health care costs. Among these solutions are patient-focused care models, leading-edge data analytics, and digital health technologies. Additionally, Capital BlueCross is growing a network of Capital Blue health and wellness centers that provide in-person service and inspiration to help people reach their health goals. Capital BlueCross is an independent licensee of the BlueCross BlueShield Association. For more information, visit capbluecross.com. Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. View source version on businesswire.com: www.businesswire.com/news/home/20181031005224/en/Catasys, Inc. Patricia Rouhafza, 310-444-4346 Copyright Business Wire 2018 Good news! Can't wait to hear the earnings call. Personally I think that $6M in billings is low balling it.
|
|
|
Post by magnus123 on Oct 31, 2018 13:27:25 GMT
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has entered into an agreement with Capital BlueCross, a community-based health insurer serving members in 21 counties in Central Pennsylvania and the Lehigh Valley. Beginning the first quarter of 2019, eligible Capital BlueCross commercial members will be able to take advantage of Catasys’ OnTrak solution, an integrated 52-week program that identifies, engages and treats members with untreated behavioral health conditions that exacerbate chronic medical disease and result in unnecessarily higher medical costs. “Reaching members who are dealing with behavioral health conditions is critically important to their treatment and recovery. By utilizing Catasys’ OnTrak, we are able to provide help to those who previously would have been difficult to identify,” said Dr. Jennifer Chambers, Chief Medical Officer and Senior Vice President Clinical Solutions. “Depression, anxiety and substance use disorders can lead to other conditions affecting overall health and wellness. In working with Catasys to identify members who are in need of valuable behavioral health services, we look forward to seeing the positive impacts of this partnership.” OnTrak specifically addresses anxiety, depression and substance use disorders among health plan members who may avoid behavioral care, and whose untreated or undertreated behavioral conditions negatively impact co-morbid medical conditions. By uniquely engaging these members in a program that produces durable behavior change, OnTrak can significantly improve the quality of members’ lives while reducing healthcare costs. “We are excited to begin this partnership with Capital BlueCross,” said Rick Anderson, Catasys President and Chief Operating Officer. “We look forward to supporting eligible members of this health plan, who are often suffering in silence, with our integrated OnTrak program that can dramatically improve their lives.” About Catasys, Inc. Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives. Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven engagement technologies. OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, Nebraska, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. About Capital BlueCross Capital BlueCross, headquartered in Harrisburg, Pa., is the leading health solutions and insurance company in Central Pennsylvania and the Lehigh Valley. A partner in the community’s health for 80 years, Capital BlueCross offers health insurance products, services and technology solutions that provide peace of mind to consumers and promote health and wellness for our customers. More than a health insurer, the company delivers innovative solutions through a family of diversified businesses that is creating a healthier future and lowering health care costs. Among these solutions are patient-focused care models, leading-edge data analytics, and digital health technologies. Additionally, Capital BlueCross is growing a network of Capital Blue health and wellness centers that provide in-person service and inspiration to help people reach their health goals. Capital BlueCross is an independent licensee of the BlueCross BlueShield Association. For more information, visit capbluecross.com. Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. View source version on businesswire.com: www.businesswire.com/news/home/20181031005224/en/Catasys, Inc. Patricia Rouhafza, 310-444-4346 Copyright Business Wire 2018 Good news! Can't wait to hear the earnings call. Personally I think that $6M in billings is low balling it. Yeah. Really nice news. “[...]Capital BlueCross serves almost 1 million people in 21 central and Lehigh Valley counties. The health network offers service from more than 18,000 providers and 40 hospitals”.(https://www.healthmarkets.com/company/capital-blue-cross/) The upcoming CC will be intresting.
|
|
|
Post by vzveteran on Oct 31, 2018 14:23:50 GMT
Good news....I Picked up some more at 7.90 yesterday...
|
|
|
Post by JHam on Oct 31, 2018 14:28:02 GMT
Good news....I Picked up some more at 7.90 yesterday... Wow, well done. I ended up adding more ONCS, trying to catch the run up to data. If CATS is still below $9 at that point I'll try and add. That said, I already have plenty of CATS and would love to see it cross back into the $9s again today.
|
|
|
Post by JHam on Nov 1, 2018 13:20:47 GMT
Big news: www.businesswire.com/news/home/20181101005258/en/ Catasys Appoints Three Healthcare Executives to Board of DirectorsNovember 01, 2018 08:30 AM Eastern Daylight Time
LOS ANGELES--(BUSINESS WIRE)--Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Edward Zecchini, Sharon Gabrielson, and Diane Seloff to its Board of Directors. Messrs. Rick Anderson and Dave Smith have stepped down as directors to accommodate the new Board members. With these changes, Catasys has a total of seven Board members.
Management Comments
Mr. Terren Peizer, Chairman and CEO of Catasys, stated, “We are pleased to welcome three accomplished executives in Ed, Sharon, and Diane to Catasys’ Board of Directors. These appointments follow Jeremiah Stone’s joining Catasys as Chief Technology Officer in July and speak to our commitment to continue improving our advanced technologies while maximizing the growth potential of our business. With more than 30 years of executive experience at various innovative healthcare and information technology businesses, Ed has the background to help Catasys expand its technology piece and further accelerate the scaling of our business. Diane possesses over 25 years of experience in the broader healthcare industry with proven success as an operator at a company with a similar services model to Catasys, which we believe will prove valuable as we look to expedite our growth trajectory. Finally, as we are starting to see traction in the Administrative Services Only (ASO), or self-funded healthcare, side of our business, we believe Sharon’s experience in business development and creative market-driven solutions will only serve to maximize our growing ASO and employer self-funded business and opportunities.”
Mr. Peizer concluded, “Each of these individuals bring a certain set of skills and experiences to the table. More significantly, our new Board members are excited about the prospects of Catasys’ business and look forward to making their contributions to expediting the Company’s growth and success in the years ahead. In the coming months, we will be evaluating potential new additions to our Board, including C-Suite executives from national health plans, which we believe will help us in executing our current strategy.”
Mr. Edward Zecchini has over 30 years of experience in the healthcare and information technology industries. Since 2014, Mr. Zecchini has served Chief Information Officer for Remedy Partners where he is responsible for building the technology and infrastructure necessary to support the implementation of bundled payment programs and other episode financing business lines. From 2010 to 2014, he served as Executive Vice President and Chief Technology Officer of Sandata Technologies, LLC, the leading provider of information technology solutions to the home healthcare industry. He also previously served as President and CEO of IT Analytics LLC, a technology consulting firm, and as Executive Vice President of Operations and Chief Information Officer of Touchstone Healthcare Partnership.
Ms. Sharon Gabrielson has dedicated over 35 years to the healthcare industry and has extensive industry experience in technology, finance, human resources, insurance, mergers and acquisitions, and business development. Ms. Gabrielson currently serves as Chair of the Mayo Clinic’s Global Business Solutions Department where she is transforming an underperforming unit into the heart of Mayo’s business diversification and profitability. She directs the domestic and international new business development opportunities for commercializing the Clinic’s competencies to deliver service-based products to the B2B and B2C markets. Ms. Gabrielson has also served as Administrator of the Clinic’s Office of Population Health (2014-15) and Vice Chair of Health System Administration (2010-15). In these roles, she was instrumental in developing a strategic plan for market penetration, scaling for growth and competing in a risk-based environment. In 1982, Ms. Gabrielson began her career as a registered nurse at Saint Mary’s Hospital where she served as a staff nurse and a charge nurse until 1990.
Ms. Diane Seloff possesses over 25 years of experience in the broader healthcare industry and has diverse experience in operations, human capital, finance, technology, strategic planning and business development in healthcare, financial services, and logistics. Since 2013, Ms. Seloff has served as Chief Operating Officer at Aspire Health where she was part of the founding leadership team. In the past five years, the Nashville-based startup has grown to become the nation’s largest provider of home-based palliative care and was acquired by Anthem in June 2018. As COO, Ms. Seloff built all the corporate functions for the company in its first two years and is responsible for running and transforming Aspire Health’s operations. She previously held senior executive roles in operations and development at other healthcare services and technology companies, including Vanderbilt University Medical Center. Ms. Seloff began her career as a management consultant—first at Arthur Andersen & Company and later at KPMG Peat Marwick.
About Catasys, Inc.
Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives.
Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.
Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven engagement technologies.
OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, Nebraska, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contacts Catasys, Inc. Patricia Rouhafza, 310-444-4346
|
|
|
Post by JHam on Nov 1, 2018 13:24:46 GMT
Mr. Peizer concluded, “Each of these individuals bring a certain set of skills and experiences to the table. More significantly, our new Board members are excited about the prospects of Catasys’ business and look forward to making their contributions to expediting the Company’s growth and success in the years ahead. In the coming months, we will be evaluating potential new additions to our Board, including C-Suite executives from national health plans, which we believe will help us in executing our current strategy.”I think that's probably a good thing
|
|
|
Post by magnus123 on Nov 2, 2018 16:35:20 GMT
Crazy move today. Soon at $13 again? Would be nice ahead of the Q3 Call.
|
|
|
Post by JHam on Nov 2, 2018 18:19:24 GMT
Good news....I Picked up some more at 7.90 yesterday... This has turned out to be a great pick based on yesterday/today’s movement. Well done!
|
|
|
Post by JHam on Nov 2, 2018 18:21:59 GMT
Crazy move today. Soon at $13 again? Would be nice ahead of the Q3 Call. I think this next earnings call, where they give guidance for 2019, will be a game changer. It may not happen immediately, but I think the next 6 months is where CATS starts to garner some attention.
|
|
|
Post by vzveteran on Nov 2, 2018 18:32:50 GMT
Good news....I Picked up some more at 7.90 yesterday... This has turned out to be a great pick based on yesterday/today’s movement. Well done! Brought my costs down a bit...not greedy....only patient at this point...glta.....Took a small position in OSB the other day at 26...dropped sharply after dividend payout...Materials sector....I've dipped in and out of this stock..taking profits leading up to the dividend date..
|
|